BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 16213190)

  • 1. Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.
    Szász I; Koroknai V; Várvölgyi T; Pál L; Szűcs S; Pikó P; Emri G; Janka E; Szabó IL; Ádány R; Balázs M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral lysophosphatidylcholine mediates α-synuclein-induced synaptic vesicle clustering.
    Lai Y; Zhao C; Tian Z; Wang C; Fan J; Hu X; Tu J; Li T; Leitz J; Pfuetzner RA; Liu Z; Zhang S; Su Z; Burré J; Li D; Südhof TC; Zhu ZJ; Liu C; Brunger AT; Diao J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310174120. PubMed ID: 37883437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia.
    Gao R; Du K; Liang J; Xia Y; Wu J; Li Y; Pan B; Wang L; Li J; Xu W
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global metabolomics profiling of colorectal cancer in Malaysian patients.
    Amir Hashim NA; Ab-Rahim S; Wan Ngah WZ; Nathan S; Ab Mutalib NS; Sagap I; A Jamal AR; Mazlan M
    Bioimpacts; 2021; 11(1):33-43. PubMed ID: 33469506
    [No Abstract]   [Full Text] [Related]  

  • 5. Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.
    Fontaine D; Figiel S; Félix R; Kouba S; Fromont G; Mahéo K; Potier-Cartereau M; Chantôme A; Vandier C
    J Lipid Res; 2020 Jun; 61(6):840-858. PubMed ID: 32265321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.
    Michalczyk A; Dołęgowska B; Heryć R; Chlubek D; Safranow K
    Lipids Health Dis; 2019 Apr; 18(1):85. PubMed ID: 30947711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.
    Roy J; Dibaeinia P; Fan TM; Sinha S; Das A
    J Lipid Res; 2019 Feb; 60(2):375-387. PubMed ID: 30504231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Marine Phospholipids Extract on the Lipid Levels of Metastatic and Nonmetastatic Prostate Cancer Patients.
    Küllenberg de Gaudry D; Taylor LA; Kluth J; Hübschle T; Fritzsche J; Hildenbrand B; Pletschen L; Schilli K; Hodina A; Griffith LS; Breul J; Unger C; Massing U
    Int Sch Res Notices; 2014; 2014():249204. PubMed ID: 27351011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.
    Raynor A; Jantscheff P; Ross T; Schlesinger M; Wilde M; Haasis S; Dreckmann T; Bendas G; Massing U
    Lipids Health Dis; 2015 Jul; 14():69. PubMed ID: 26162894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma.
    Wang L; Chi PD; Chen H; Xiang J; Xia ZJ; Zhang YJ
    Tumour Biol; 2014 Mar; 35(3):2141-9. PubMed ID: 24122233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylcholine inhibits membrane-associated SNARE complex disassembly.
    Shin L; Wang S; Lee JS; Flack A; Mao G; Jena BP
    J Cell Mol Med; 2012 Aug; 16(8):1701-8. PubMed ID: 21883893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.
    Zhao Z; Xu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3739-42. PubMed ID: 19734112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P MRS analysis of the phospholipid composition of the peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) of patients with acute leukemia (AL).
    Kuliszkiewicz-Janus M; Tuz MA; Kiełbiński M; Jaźwiec B; Niedoba J; Baczyński S
    Cell Mol Biol Lett; 2009; 14(1):35-45. PubMed ID: 18839072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid changes occuring in the course of hematological cancers.
    Kuliszkiewicz-Janus M; Małecki R; Mohamed AS
    Cell Mol Biol Lett; 2008; 13(3):465-74. PubMed ID: 18463797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia--a 31P MRS in vitro study.
    Kuliszkiewicz-Janus M; Tuz MA; Kiełbiński M; Baczyński S; Jaźwiec B; Sladowska H
    Cell Mol Biol Lett; 2008; 13(1):58-66. PubMed ID: 17952375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status.
    Taylor LA; Arends J; Hodina AK; Unger C; Massing U
    Lipids Health Dis; 2007 Jul; 6():17. PubMed ID: 17623088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia.
    Kuliszkiewicz-Janus M; Tuz MA; Baczyński S
    Biochim Biophys Acta; 2005 Oct; 1737(1):11-5. PubMed ID: 16213190
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.